SC 13G Filing

Company

Aptose Biosciences Inc.

Filed

December 27, 2019

Accession Number

0001493152-19-019769

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →